Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Li, Lihua ^a   Yin, Xueyan ^a   Yao, Chaoyong ^a   Zhu, Xuechuang ^a   Wu, Xinhua ^a  

^a DALI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIHYPERTENSIVE AGENT; GLUCOSE; LIPID; PARATHYROID HORMONE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE; SEX RATIO; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; VITAMIN D;

EID: 84865073922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043344     Document Type: Article

References (32)

1. DeLuca HF, (1979) The vitamin D system in the regulation of calcium and phosphorus metabolism. Nutr Rev 37: 161-193.
2. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069.
3. Kim MK, Il KM, Won OK, Kwon HS, Lee JH, et al. (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 73: 330-338.
4. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, et al. (2010) Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 28: 1821-1828.
5. Forman JP, Curhan GC, Taylor EN, (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52: 828-832.
6. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G, (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55: 792-798.
7. Bhandari SK, Pashayan S, Liu IL, Rasgon SA, Kujubu DA, et al. (2011) 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) 13: 170-177.
8. Lu L, Yu Z, Pan A, Hu FB, Franco OH, et al. (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32: 1278-1283.
9. Chan R, Chan D, Woo J, Ohlsson C, Mellstrom D, et al. (2012) Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens 26: 20-27.
10. Dorjgochoo T, Ou SX, Xiang YB, Yang G, Cai Q, et al. (2012) Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies. Br J Nutr: 1-10.
11. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, et al. (2009) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20: 133-140.
12. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G, (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55: 792-798.
13. He JL, Scragg RK, (2011) Vitamin D, parathyroid hormone, and blood pressure in the National Health and Nutrition Examination Surveys. Am J Hypertens 24: 911-917.
14. Taylor EN, Curhan GC, Forman JP, (2008) Parathyroid hormone and the risk of incident hypertension. J Hypertens 26: 1390-1394.
15. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2002) Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 40: 920-927.
16. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147.
17. Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261: 558-565.
18. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E, (2007) Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30: 1549-1555.
19. Margolis KL, Martin LW, Ray RM, Kerby TJ, Allison MA, et al. (2012) A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol 175: 22-32.
20. Elamin MB, Abu ENO, Elamin KB, Fatourechi MM, Alkatib AA, et al. (2011) Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 1931-1942.
21. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR, (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30: 771-777.
22. Holick MF, (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
23. Holick MF, (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81: 353-373.
24. Rostand SG, (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30: 150-156.
25. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90: 387-392.
26. Vaidya A, Forman JP, (2010) Vitamin D and hypertension: current evidence and future directions. Hypertension 56: 774-779.
27. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR, (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57: 63-69.
28. Dong J, Wong SL, Lau CW, Lee HK, Ng CF, et al. (2012) Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J [Epub ahead of print].
29. Pilz S, Tomaschitz A, Ritz E, Pieber TR, (2009) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6: 621-630.
30. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, et al. (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26: 27-33.
31. Rashid G, Bernheim J, Green J, Benchetrit S, (2007) Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 292: F1215-1218.
32. Rubanyi GM, Polokoff MA, (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415.